US Patent Issued to Achillion Pharmaceuticals on Nov. 25 for "Pharmaceutical compounds for the treatment of complement mediated disorders" (Connecticut Inventors)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,479,856, issued on Nov. 25, was assigned to Achillion Pharmaceuticals Inc. (Boston).

"Pharmaceutical compounds for the treatment of complement mediated disorders" was invented by Jason Allan Wiles (Madison, Conn.), Venkat Rao Gadhachanda (Hamden, Conn.) and Kyle J. Eastman (Killingworth, Conn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure provides pharmaceutical compounds to treat medical disorders, such as complement-mediated disorders, including complement Cl-mediated disorders."

The patent was filed on March 20, 2020, under Application No. 17/440,665.

*For further information, including images, charts and tables, please visit: http...